Anti-factor Xa during unfractionated heparin therapy in critically ill patients: Development of prediction models using machine learning
Objective Unfractionated heparin (UFH) is a widely used therapy in intensive care units (ICUs) and is associated with an increased risk of serious adverse events or death if the therapeutic target is not reached quickly. Adjusting UFH dosage is challenging, and no reliable algorithms exist for predi...
Saved in:
| Main Authors: | Boris Delange, Guillaume Bouzillé, Pauline Guillot, Anaëlle Bichon, Océane Bernard de Lajartre, Isabelle Gouin, Yoann Launey, Alexandre Mansour, Mathieu Lesouhaitier, Jean-Marc Tadié, Arnaud Gacouin, Marc Cuggia, Adel Maamar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-04-01
|
| Series: | Digital Health |
| Online Access: | https://doi.org/10.1177/20552076241305957 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
56 Analysis of Xa Levels and PTTs During the First 48 Hours of Anticoagulation with Unfractionated Heparin Infusion
by: Kaitlyn Loi
Published: (2025-05-01) -
Association of obesity on short- and long-term survival in patients with moderate to severe pneumonia-related ARDS: a retrospective cohort study
by: Arnaud Gacouin, et al.
Published: (2025-04-01) -
Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: A comparison between aPTT and anti-factor Xa activity level monitoring
by: Merijn C. Reuland, et al.
Published: (2025-06-01) -
Are presentations of thoracic CT performed on admission to the ICU associated with mortality at day-90 in COVID-19 related ARDS?
by: Alexia Le Corre, et al.
Published: (2025-06-01) -
Automatic continuous P0.1 measurements during weaning from mechanical ventilation: a clinical study
by: Flora Delamaire, et al.
Published: (2025-04-01)